Alkem Laboratories

Alkem Laboratories EBIT

The EBIT of Alkem Laboratories (ALKEM.NS) as of Oct 24, 2026 is 30.32 B INR. In the previous year, EBIT was 26.14 B INR — a change of 15.97% (higher).

EBIT

30.32 BINR

YoY

15.97%

Last updated:

In 2026, Alkem Laboratories's EBIT was 30.32 B INR, a 15.97% increase from the 26.14 B INR EBIT recorded in the previous year.

The Alkem Laboratories EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2022
18.85 B INR
Jan 1, 2023
13.34 B INR
Jan 1, 2024
21.19 B INR
Jan 1, 2025
26.14 B INR
Jan 1, 2026
30.32 B INR
Jan 1, 2027 (e)
28.75 B INR
Jan 1, 2028 (e)
33.46 B INR
Jan 1, 2029 (e)
38.22 B INR
The Alkem Laboratories EBIT history
YEAREBITYoY
est38.22 BINR+14.25%
est33.46 BINR+16.36%
est28.75 BINR-5.15%
30.32 BINR+15.97%
26.14 BINR+23.38%
21.19 BINR+58.81%
13.34 BINR-29.23%
18.85 BINR-0.31%
18.91 BINR+48.54%
12.73 BINR+26.74%
10.04 BINR+12.34%
8.94 BINR-1.84%
9.11 BINR+17.94%
7.72 BINR+106.17%
3.75 BINR-8.14%
4.08 BINR-4.84%
4.29 BINR+13.06%
3.79 BINR+33.84%
2.83 BINR+44.50%
1.96 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Alkem Laboratories Revenue

Alkem Laboratories Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
105.12 B INR
18.85 B INR
16.46 B INR
Jan 1, 2023
114.40 B INR
13.34 B INR
9.84 B INR
Jan 1, 2024
124.39 B INR
21.19 B INR
17.96 B INR
Jan 1, 2025
128.05 B INR
26.14 B INR
21.65 B INR
Jan 1, 2026
147.12 B INR
30.32 B INR
23.02 B INR
Jan 1, 2027 (e)
166.91 B INR
28.75 B INR
23.16 B INR
Jan 1, 2028 (e)
185.63 B INR
33.46 B INR
27.01 B INR
Jan 1, 2029 (e)
205.20 B INR
38.22 B INR
30.91 B INR

Alkem Laboratories Margins

Alkem Laboratories stock margins

The Alkem Laboratories margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Alkem Laboratories. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Alkem Laboratories.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
59.25 %
17.93 %
15.65 %
Jan 1, 2023
56.45 %
11.66 %
8.60 %
Jan 1, 2024
59.55 %
17.03 %
14.44 %
Jan 1, 2025
62.06 %
20.42 %
16.91 %
Jan 1, 2026
65.38 %
20.61 %
15.65 %
Jan 1, 2027 (e)
65.38 %
17.23 %
13.87 %
Jan 1, 2028 (e)
65.38 %
18.02 %
14.55 %
Jan 1, 2029 (e)
65.38 %
18.63 %
15.06 %

Alkem Laboratories Stock analysis

What does Alkem Laboratories do? Alkem Laboratories Ltd is a leading Indian pharmaceutical company that was founded in 1973 and is headquartered in Mumbai. The company's main business model includes the development, manufacturing, and distribution of pharmaceutical formulations and active ingredients. Alkem Laboratories specializes in generics, branded drugs, and biosimilars, offering a comprehensive range of medical solutions. The company is divided into several divisions, including drug research and development, manufacturing, marketing, and sales. It focuses particularly on chronic diseases such as diabetes, cardiovascular diseases, cancer, neurological disorders, and infectious diseases. Alkem Laboratories employs over 20,000 employees worldwide and aims to improve the health and well-being of people globally. It offers a wide range of both prescription and over-the-counter products, including antibiotics, antifungals, cardiology, gastroenterology, urology, neurology, oncology, psychiatry, dermatology, and pediatrics. The company is committed to developing biosimilars that provide more affordable treatment options for serious diseases such as cancer and autoimmune diseases. It has developed an extensive portfolio of biosimilars, including Rituximab, Trastuzumab, and Adalimumab. Alkem Laboratories has also invested in research and development to create innovative solutions for the healthcare industry. It has established research centers in India, the USA, and Europe to discover new active ingredients, optimize processes, and develop innovative products. The company aims to lead in maintaining the highest quality standards and complying with strict regulatory requirements. Alkem Laboratories has certified facilities in India and the USA according to GMP guidelines. It also has a strong presence in the international pharmaceutical industry community and is a member of organizations such as the International Generic and Biosimilar Medicines Association, the Indian Pharmaceutical Alliance, and the US Pharmaceutical Research and Manufacturers of America. Overall, Alkem Laboratories is characterized by its extensive experience in the pharmaceutical industry and its commitment to the health and well-being of people worldwide. The company strives to create innovative solutions for the medical sector and aims to utilize its cutting-edge technology and expertise to meet the needs of patients globally. Alkem Laboratories is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Alkem Laboratories's EBIT

Alkem Laboratories's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Alkem Laboratories's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Alkem Laboratories's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Alkem Laboratories’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Alkem Laboratories stock

EBIT of Alkem Laboratories is 30.32 B INR in 2026.

EBIT of Alkem Laboratories changed from 26.14 B INR to 30.32 B INR, representing a 15.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Alkem Laboratories since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Alkem Laboratories historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Alkem Laboratories

All Key Metrics — Alkem Laboratories